HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-34a expression, epigenetic regulation, and function in human placental diseases.

Abstract
Preeclampsia (PE) is the major pregnancy-induced hypertensive disorder responsible for maternal and fetal morbidity and mortality that can be associated with intrauterine growth restriction (IUGR). PE and IUGR are thought to be due to a placental defect, occurring early during pregnancy. Several placental microRNAs (miRNAs) have been shown to be deregulated in the context of placental diseases and could thus play a role in the pathophysiology of PE. Here, we show that pri-miR-34a is overexpressed in preeclamptic placentas and that its placental expression is much higher during the first trimester of pregnancy than at term, suggesting a possible developmental role. We explored pri-miR-34a regulation and showed that P53, a known activator of miR-34a, is reduced in all pathological placentas and that hypoxia can induce pri-miR-34a expression in JEG-3 cells. We also studied the methylation status of the miR-34a promoter and revealed hypomethylation in all preeclamptic placentas (associated or not with IUGR), whereas hypoxia induced a hypermethylation in JEG-3 cells at 72 h. Despite the overexpression of pri-miR-34a in preeclampsia, there was a striking decrease of the mature miR-34a in this condition, suggesting preeclampsia-driven alteration of pri-miR-34a maturation. SERPINA3, a protease inhibitor involved in placental diseases, is elevated in IUGR and PE. We show here that miR-34a overexpression in JEG-3 downregulates SERPINA3. The low level of mature miR-34a could thus be an important mechanism contributing to SERPINA3 upregulation in placental diseases. Overall, our results support a role for miR-34a in the pathophysiology of preeclampsia, through deregulation of the pri-miRNA expression and its altered maturation.
AuthorsLudivine Doridot, Dorothée Houry, Harald Gaillard, Sonia T Chelbi, Sandrine Barbaux, Daniel Vaiman
JournalEpigenetics (Epigenetics) Vol. 9 Issue 1 Pg. 142-51 (Jan 2014) ISSN: 1559-2308 [Electronic] United States
PMID24081307 (Publication Type: Journal Article)
Chemical References
  • MIRN34 microRNA, human
  • MicroRNAs
  • SERPINA3 protein, human
  • Serpins
  • Tumor Suppressor Protein p53
Topics
  • Cell Line, Tumor
  • Choriocarcinoma (genetics, metabolism)
  • DNA Methylation
  • Epigenesis, Genetic
  • Female
  • Humans
  • Hypoxia (metabolism)
  • MicroRNAs (genetics, metabolism)
  • Placenta Diseases (genetics, metabolism)
  • Pre-Eclampsia (genetics, metabolism)
  • Pregnancy
  • Promoter Regions, Genetic
  • Serpins (genetics, metabolism)
  • Tumor Suppressor Protein p53 (genetics, metabolism)
  • Uterine Neoplasms (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: